Thermo Fisher Scientific
OrganizationHeard in 24 episodes across 8 shows since Oct 2025
Thermo Fisher Scientific Inc. is an American multinational life sciences and clinical research company. It is a global supplier of analytical instruments, clinical development solutions, specialty diagnostics, laboratory equipment, and biotechnology services. The company was formed in 2006 through the merger of Thermo Electron and Fisher Scientific.
Episodes
This week
Expert statements
Share of the conversation
Mentions of Thermo Fisher Scientific per 1,000 mentions of anything, 7-day rolling, across the podcasts PodLume Trends follows.
Show the data
| Day | Share (7-day) | Mentions |
|---|---|---|
| Sep 4 | 0.01‰ | 1 |
| Sep 30 | 0.02‰ | 2 |
| Oct 14 | 0.01‰ | 1 |
| Oct 15 | 0.02‰ | 1 |
| Oct 19 | 0.03‰ | 1 |
| Oct 20 | 0.03‰ | 1 |
| Oct 26 | 0.03‰ | 3 |
| Oct 27 | 0.04‰ | 2 |
| Nov 4 | 0.01‰ | 1 |
| Nov 6 | 0.02‰ | 1 |
Email alert
Email me when Thermo Fisher Scientific comes up on a podcast
One email a week at most, with the new episodes that mention Thermo Fisher Scientific. Free, no account needed, unsubscribe in one click.
What experts have said about Thermo Fisher Scientific
14 statements · 14 positive
Thermo Fisher has a multi-year growth run ahead.
“I think multi-year run is ahead”
Open the episode · Mad Money w/ Jim Cramer 10/26/26Listen at 17:21
Thermo Fisher has finally broken out after years of weakness.
“This stock has finally broken out.”
Open the episode · Rising Yields & Rally Risk: The Investment Committee's Strategy 10/14/26Listen at 41:58
Cramer recommends buying Thermo Fisher at 19 times earnings
“I think you can buy it at this level. I know at 19 times earnings, I'm surprised it is that cheap.”
Open the episode · Mad Money w/ Jim Cramer 5/6/26Listen at 38:52
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.
Episodes
24 episodes featuring Thermo Fisher Scientific, newest first
- Nov 6, 2026
Data-center backlash forces markets to rethink AI growthThe Compound and FriendsNov 6, 2026 - Nov 4, 2026
Markets rotate from AI infrastructure toward life sciencesMad Money w/ Jim CramerNov 4, 2026 - Oct 27, 2026
Anthropic’s filing tests the durability of the AI tradeThe Compound and FriendsOct 27, 2026 - Oct 27, 2026
Cramer tests the data-center revival beyond AIMad Money w/ Jim CramerOct 27, 2026 - Oct 26, 2026
AI boom tests markets as executives confront recovery and cyber riskMad Money w/ Jim CramerOct 26, 2026 - Oct 21, 2026
Meta and Tesla test the market’s AI spending patienceClosing BellOct 21, 2026